HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Onodera Selected Research

U12 small nuclear RNA

2/2014Minor splicing pathway is not minor any more: implications for the pathogenesis of motor neuron diseases.
10/2013Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Onodera Research Topics

Disease

19Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 02/2007
14Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
11/2021 - 04/2009
12Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 05/2004
8Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
11/2020 - 04/2008
8Ataxia (Dyssynergia)
10/2020 - 03/2005
7Dementia (Dementias)
04/2015 - 03/2005
6Stroke (Strokes)
12/2020 - 05/2016
5Motor Neuron Disease (Primary Lateral Sclerosis)
07/2021 - 10/2009
5Ischemic Stroke
12/2020 - 01/2017
5Cerebral Small Vessel Diseases
02/2020 - 04/2009
5Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2020 - 03/2004
5Parkinson Disease (Parkinson's Disease)
01/2017 - 04/2008
4Early-onset ataxia with oculomotor apraxia and hypoalbuminemia
01/2021 - 01/2009
4Cognitive Dysfunction
03/2019 - 01/2016
3Corticobasal Degeneration
01/2022 - 07/2010
3Hypertension (High Blood Pressure)
12/2020 - 11/2011
3Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
10/2020 - 04/2007
3Brain Ischemia (Cerebral Ischemia)
10/2020 - 01/2017
3Huntington Disease (Huntington's Disease)
01/2020 - 03/2004
3Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
01/2020 - 05/2002
3Atrophy
10/2019 - 02/2009
3Disease Progression
02/2017 - 11/2011
3Alzheimer Disease (Alzheimer's Disease)
06/2010 - 11/2007
2Amyloidosis
05/2022 - 11/2005
2Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
02/2022 - 03/2019
2CADASIL
08/2021 - 03/2013
2Cerebellar Ataxia (Dysmetria)
12/2020 - 01/2020
2Infections
11/2020 - 07/2003
2Brain Diseases (Brain Disorder)
01/2020 - 02/2009
2X-Linked Bulbo-Spinal Atrophy
01/2020 - 10/2009
2Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)
01/2020 - 04/2007
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
06/2011 - 07/2010
2Apraxias (Dyspraxia)
01/2010 - 03/2007
2autosomal recessive 1 Spinocerebellar ataxia
11/2009 - 01/2009
2Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
03/2005 - 01/2003
1Chronic Renal Insufficiency
01/2022
1Osteoporosis
01/2022
1Parkinsonian Disorders (Parkinsonism)
12/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2021
1Optic Neuritis (Retrobulbar Neuritis)
09/2021
1Lacunar Stroke
09/2021
1Atherosclerosis
09/2021
1Intracranial Aneurysm (Cerebral Aneurysm)
08/2021
1Movement Disorders (Movement Disorder)
01/2021
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Inflammation (Inflammations)
12/2020
1Transient Ischemic Attack
12/2020
1Hemorrhage
12/2020
1Obesity
11/2020
1Periodontitis
11/2020

Drug/Important Bio-Agent (IBA)

16DNA-Binding Proteins (DNA Binding Protein)IBA
01/2022 - 05/2007
14Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2003
9polyglutamineIBA
10/2020 - 05/2002
6Pharmaceutical PreparationsIBA
12/2021 - 06/2011
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2004
6Peptide Hydrolases (Proteases)FDA Link
01/2017 - 06/2010
5High-Temperature Requirement A Serine Peptidase 1IBA
11/2021 - 01/2017
5UbiquitinIBA
01/2017 - 02/2007
4Glucose (Dextrose)FDA LinkGeneric
12/2020 - 01/2017
4Oxygen (Dioxygen)IBA
10/2020 - 06/2007
4Serine (L-Serine)FDA Link
01/2017 - 06/2010
4alpha-SynucleinIBA
06/2010 - 04/2007
3SteroidsIBA
05/2020 - 07/2003
3Amyloid (Amyloid Fibrils)IBA
03/2020 - 01/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019 - 10/2008
3Transforming Growth Factors (Transforming Growth Factor)IBA
11/2019 - 01/2017
3ORALIT (ORS)IBA
03/2019 - 01/2016
3Retinaldehyde (Retinal)IBA
03/2013 - 03/2005
3Transforming Growth Factor beta (TGF-beta)IBA
08/2011 - 04/2009
3Presenilin-1IBA
01/2008 - 03/2005
2Arginine (L-Arginine)FDA Link
01/2020 - 01/2017
2U12 small nuclear RNAIBA
02/2014 - 10/2013
2Nuclear Proteins (Protein, Nuclear)IBA
01/2014 - 08/2008
2RNA (Ribonucleic Acid)IBA
01/2014 - 08/2006
2Fibronectins (Fibronectin)IBA
05/2011 - 06/2010
2AldehydesIBA
11/2009 - 01/2009
1patisiranIBA
05/2022
1mecobalamin (methylcobalamin)IBA
01/2022
1candesartanIBA
11/2021
1Antihypertensive Agents (Antihypertensives)IBA
09/2021
1Anti-Bacterial Agents (Antibiotics)IBA
08/2021
1Cysteine (L-Cysteine)FDA Link
08/2021
1Protein AggregatesIBA
07/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021
1ElementsIBA
01/2021
1deoxyribonuclease II (DNASE II)IBA
01/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
12/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020
1Protective AgentsIBA
12/2020
1cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)- somatostatin (CHP1)IBA
12/2020
1Indicators and Reagents (Reagents)IBA
11/2020
1Immunoglobulin G (IgG)IBA
11/2020

Therapy/Procedure

14Therapeutics
05/2022 - 07/2003
2Stem Cell Transplantation
02/2022 - 03/2019
2Tracheostomy
01/2022 - 11/2018
2Cell- and Tissue-Based Therapy (Cell Therapy)
10/2020 - 01/2017
1Polypharmacy
01/2022
1General Anesthesia
12/2020
1Thrombectomy
12/2020